Cladribine from Japan
Cladribine is a purine nucleoside analog (2-chlorodeoxyadenosine) used in hairy cell leukemia and multiple sclerosis, featuring chlorinated purine heterocycle. HTS 2934.99.4700 as halogenated heterocyclic drug per Chapter notes. Synthetic API meeting purity standards.
Duty Rate — Japan → United States
23.8%
Rate breakdown
9903.04.6211.3%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Chlorine content verification by NMR; orphan drug status documentation; multiple sclerosis indication requires specific labeling